Quantitative Systematic Strategies LLC Mirati Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$132.13 - $177.45 $479,235 - $643,611	-3,627 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $562,032 - $701,486	-3,903 Reduced 51.83%	3,627 $586,000
Q1 2021 May 06, 2021	BUY	$158.92 - $221.61 $47,517 - $66,261	299 Added 4.13%	7,530 $1.29 Million
Q4 2020 Feb 09, 2021	SELL	$162.05 - $240.27 $22,038 - $32,676	-136 Reduced 1.85%	7,231 $1.59 Million
Q3 2020 Nov 09, 2020	SELL	$113.26 - $167.27 $571,056 - $843,375	-5,042 Reduced 40.63%	7,367 $1.22 Million
Q2 2020 Aug 04, 2020	BUY	$72.01 - $120.39 $489,379 - $818,170	6,796 Added 121.08%	12,409 $1.42 Million
Q1 2020 May 06, 2020	SELL	$69.78 - $116.21 $27,632 - $46,019	-396 Reduced 6.59%	5,613 $431,000
Q4 2019 Feb 11, 2020	BUY	$70.76 - $128.86 $94,040 - $171,254	1,329 Added 28.4%	6,009 $774,000
Q3 2019 Nov 07, 2019	BUY	$77.91 - $109.6 $159,325 - $224,132	2,045 Added 77.61%	4,680 $365,000
Q2 2019 Jul 25, 2019	BUY	$59.49 - $104.71 $156,756 - $275,910	2,635 New	2,635 $271,000
Q1 2019 Apr 15, 2019	SELL	$43.65 - $78.95 $405,377 - $733,208	-9,287 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$32.0 - $47.43 $146,912 - $217,751	4,591 Added 97.76%	9,287 $394,000
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $16,532 - $22,007	351 Added 8.08%	4,696 $221,000
Q2 2018 Aug 07, 2018	BUY	$26.05 - $52.4 $113,187 - $227,678	4,345 New	4,345 $214,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.